FLXN
Flexion Therapeutics, Inc.
FLXN
FLXN
Delisted
FLXN was delisted on the 18th of November, 2021.
141 hedge funds and large institutions have $580M invested in Flexion Therapeutics, Inc. in 2020 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 45 increasing their positions, 40 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
141
Holders Change
+6
Holders Change %
+4.44%
% of All Funds
2.5%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
26
Increased
45
Reduced
40
Closed
20
Calls
$1.54M
Puts
$3.33M
Net Calls
-$1.79M
Net Calls Change
-$417K
Top Buyers
| 1 |
O
OrbiMed
New York
|
+$7.2M |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$6M |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$5.78M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$3.99M |
| 5 |
PFC
Phocas Financial Corp
Alameda,
California
|
+$2.66M |
Top Sellers
| 1 |
MVP
Miller Value Partners
Sarasota,
Florida
|
-$12.4M |
| 2 |
CC
Clearline Capital
New York
|
-$4.16M |
| 3 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
-$2.95M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$2.15M |
| 5 |
D.E. Shaw & Co
New York
|
-$1.83M |
